Cargando…
489. Validation of the SHEA/IDSA Severity Criteria to Predict Poor Outcomes Among Inpatients and Outpatients With Clostridium difficile Infection
BACKGROUND: The SHEA/IDSA clinical practice guidelines suggest using leukocytosis (WBC ≥15,000 cells/µl) and serum creatinine (SCr) to identify severe cases of Clostridium difficile infection (CDI). It is unclear whether these criteria adequately predict poor outcomes among patients with CDI in the...
Autores principales: | Stevens, Vanessa, Jones, Makoto, Nelson, Richard E, Khader, Karim, Samore, Matthew, Rubin, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254106/ http://dx.doi.org/10.1093/ofid/ofy210.498 |
Ejemplares similares
-
Discordance of SHEA/IDSA Clostridium difficile Disease Severity Scale in Solid Organ Transplant Patients
por: Lee, Tiffany, et al.
Publicado: (2017) -
1655 Lack of Adherence to SHEA-IDSA Treatment Guidelines for Severe Clostridium difficile Infection is Associated with Increased Mortality
por: Patel, Ishan, et al.
Publicado: (2014) -
Navigating the 2021 update to the IDSA/SHEA Clostridioides difficile guidelines: An ethical approach to equitable patient care
por: Shoff, Christopher J., et al.
Publicado: (2022) -
1630 Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multi-State Model
por: Stevens, Vanessa, et al.
Publicado: (2014) -
Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines
por: Bishop, Emma Jane, et al.
Publicado: (2022)